BU-NOT-SET

CONTACT US
Three challenges pharma companies can overcome when choosing the right OSD partner
  • Drug product
  • Industry trends
pharma challenges
Insight
Sustainable pharmaceutical supply chains with the Science Based Targets initiative
  • Sustainability
SBTi
Insight
How CDMO partnerships can accelerate vaccine development
vaccine development
Insight
Optimising extractables and leachables testing
  • Analytical chemistry
  • Drug product
Optimising Extractables and Leachables Testing
Insight
Ready-to-use (RTU) pre-filled syringes and cartridges system
  • Drug product
  • Manufacturing
vials
Fact sheet
Recipharm’s latest investment will help meet blow-fill-seal (BFS) demand
  • Drug product
  • Manufacturing
blow fill-seal
Insight
Which biologics trends in the OSD space are set to impact drug development in 2023?
  • Drug product
  • Industry trends
Biologics trends in OSD
Insight
What are the key learnings from 2022 in pharma?
  • Drug product
  • Industry trends
Learnings 2022
Insight
Overcoming the pitfalls of pre-filled syringe filling
  • Drug product
  • Manufacturing
Pre-filled syringe pitfalls
Insight
Insight
  • Manufacturing
Countdown to EU FMD deadline
Fact sheet
  • Manufacturing
Stand-alone serialisation services
Insight
  • Industry trends
Post-Brexit medicines - stuck in the UK?
Insight
  • Industry trends
Brexit: What will it mean for the regulation of medicines?
Insight
  • Analytical chemistry
Stability study trends - Outsourcing stability studies
Insight
  • Industry trends
The EMA relocation: Brexit and the UK's pharmaceutical industry
Insight
  • Drug product
Prevention not cure: avoiding a European prescription opioid epidemic
Insight
  • Manufacturing
Six months and counting: industry views
Insight
  • Manufacturing
Six months until DSCSA… industry comments